by Alex Kadhim
Investigators at the Medical College of Wisconsin, collaborating with microbiome researchers at Memorial Sloan Kettering Cancer Center, have found the addition of the IL-23p19–blocking...
by Alex Kadhim
Researchers at the Fred Hutchinson Cancer Center have found specific donor dendritic cell subsets are dominant drivers of gastrointestinal acute GVHD that can be therapeutically targeted to...
by Alex Kadhim
Two recent letters in Transplantation and Cellular Therapy debate how umbilical cord blood (UCB) should be positioned in modern donor-selection guidance now that post-transplant...
by Alex Kadhim
Researchers at City of Hope and Memorial Sloan Kettering Cancer Center, with collaborators from the University of Chicago, Fred Hutchinson Cancer Center, and Mayo Clinic, have found that...
by Alex Kadhim
Researchers from the European Society for Blood and Marrow Transplantation (EBMT) have found that using posttransplant cyclophosphamide (ptCy) for graft-versus-host disease (GVHD) prophylaxis in...
by Alex Kadhim
Researchers at Roswell Park Comprehensive Cancer Center and the University of Minnesota have found that targeting the pentose phosphate pathway (PPP) in donor T cells can significantly reduce the...